PMCB (PharmaCyte Biotech) Net Margin % : 0.00% (As of Jan. 2025)

PharmaCyte Biotech Net Margin % Chart

PharmaCyte Biotech Annual Data
	Trend	Apr15	Apr16	Apr17	Apr18	Apr19	Apr20	Apr21	Apr22	Apr23	Apr24
Net Margin %		Get a 7-Day Free Trial					-	-	-	-	-

PharmaCyte Biotech Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Net Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of PharmaCyte Biotech's Net Margin %

For the Biotechnology subindustry, PharmaCyte Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaCyte Biotech's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaCyte Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where PharmaCyte Biotech's Net Margin % falls into.

PharmaCyte Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

PharmaCyte Biotech's Net Margin for the fiscal year that ended in Apr. 2024 is calculated as

PharmaCyte Biotech's Net Margin for the quarter that ended in Jan. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCyte Biotech  (NAS:PMCB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

PharmaCyte Biotech Net Margin % Related Terms

Thank you for viewing the detailed overview of PharmaCyte Biotech's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCyte Biotech Business Description